Ginsenoside Rd therapy improves histological and functional recovery in a rat model of inflammatory bowel disease
Citations Over TimeTop 17% of 2020 papers
Abstract
Ginsenoside Rd (GRd) is a biologically active component of ginseng that stimulates the proliferation of endogenous stem cells. The objective of our research was to evaluate the utility of GRd in gastrointestinal mucosal regeneration in a rat model of inflammatory bowel disease (IBD) and to clarify whether GRd exerts its pharmacological effects by modulating endogenous intestinal stem cells. The IBD rat model was established via subcutaneous injection of indomethacin, and 10, 20, or 40 mg/kg GRd or an equal volume of physiological saline was then administered orally to rats in different groups every day for seven consecutive days. We observed that GRd treatment, especially 20 mg/kg GRd, significantly reduced indomethacin‐induced damage compared with that in the control group. By measuring the mRNA and protein levels of the intestinal stem cell markers Bmi and Msi‐1 and the intestinal epithelial cell marker CDX‐2 as well as by double‐labelling these markers with 5‐bromo‐2‐deoxyuridine (BrdU), we inferred that GRd could stimulate the proliferation and differentiation of endogenous intestinal stem cells in IBD model rats, leading to improved recovery of intestinal function.
Related Papers
- → Sucrose Induced HMGR to Promote Ginsenoside Biosynthesis in the Growth of Wild Cultivated Ginseng (Panax ginseng)(2022)9 cited
- → Quantitative estimation of ginsenosides in different ages of <i>Panax vietnamensis</i> and their anti-proliferation effects in hela cells(2015)8 cited
- → Analysis of major ginsenosides in various ginseng samples(2019)16 cited
- Ginsenosides from the Roots of Korean Cultivated-Wild Ginseng(2008)
- → [Characterization of tissue expression of ginsenoside biosynthetic gene expression in Panax ginseng].(2017)2 cited